Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Emerence Crompot"'
Autor:
Nathan Dubois, Emerence Crompot, Nathalie Meuleman, Dominique Bron, Laurence Lagneaux, Basile Stamatopoulos
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Chronic lymphocytic leukemia (CLL) is caused by the accumulation of malignant B cells due to a defect in apoptosis and the presence of small population of proliferating cells principally in the lymph nodes. The abnormal survival of CLL B cells is exp
Externí odkaz:
https://doaj.org/article/5d6fd7850b9544ca96f0282e2f84e49f
Publikováno v:
BMC Cell Biology, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Mesenchymal stromal cells (MSCs) become an attractive research topic because of their crucial roles in tissue repair and regenerative medicine. Foreskin is considered as a valuable tissue source containing immunotherapeutic MSCs (
Externí odkaz:
https://doaj.org/article/df26dc312ac94f55b8cf854fe7331bb4
Autor:
Gordana Raicevic, Mehdi Najar, Hélène Busser, Emerence Crompot, Dominique Bron, Michel Toungouz, Laurence Lagneaux
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract Due to their immunomodulatory and regenerative properties, Mesenchymal stromal cells (MSC) have generated major interests in several clinical settings including transplantation and inflammatory diseases. MSC functions can be influenced by th
Externí odkaz:
https://doaj.org/article/c4f45acc6d314b89b970f6886741dffd
Autor:
Emerence Crompot, Michael Van Damme, Karlien Pieters, Marjorie Vermeersch, David Perez-Morga, Philippe Mineur, Marie Maerevoet, Nathalie Meuleman, Dominique Bron, Laurence Lagneaux, Basile Stamatopoulos
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
Interactions between chronic lymphocytic leukemia (CLL) B cells and the bone marrow (BM) microenvironment play a major function in the physiopathology of CLL. Extracellular vesicles (EVs), which are composed of exosomes and microparticles, play an im
Externí odkaz:
https://doaj.org/article/9b128f218c124d75bfed5bc98bd0931f
Autor:
Emerence Crompot, Michael Van Damme, Hugues Duvillier, Karlien Pieters, Marjorie Vermeesch, David Perez-Morga, Nathalie Meuleman, Philippe Mineur, Dominique Bron, Laurence Lagneaux, Basile Stamatopoulos
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127209 (2015)
BackgroundMicroparticles (MPs), also called microvesicles (MVs) are plasma membrane-derived fragments with sizes ranging from 0.1 to 1μm. Characterization of these MPs is often performed by flow cytometry but there is no consensus on the appropriate
Externí odkaz:
https://doaj.org/article/6b4fe0fbd1cb4024b15f98c4f7ff29a3
Autor:
Olivier Cabaud, Ludovic Berger, Emerence Crompot, José Adélaide, Pascal Finetti, Sèverine Garnier, Arnaud Guille, Nadine Carbuccia, Anne Farina, Emilie Agavnian, Max Chaffanet, Anthony Gonçalves, Emmanuelle Charafe-Jauffret, Emilie Mamessier, Daniel Birnbaum, François Bertucci, Marc Lopez
Publikováno v:
Molecular Cancer Therapeutics. 21:1227-1235
Antibody–drug conjugates (ADC) represent a fast-growing drug class in oncology. However, ADCs are associated with resistance, and therapies able to overcome it are of utmost importance. Recently, enfortumab vedotin-ejfv (EV) was approved in nectin-
Autor:
Marc Lopez, François Bertucci, Daniel Birnbaum, Emilie Mamessier, Emmanuelle Charafe-Jauffret, Anthony Gonçalves, Max Chaffanet, Emilie Agavnian, Anne Farina, Nadine Carbuccia, Arnaud Guille, Sèverine Garnier, Pascal Finetti, José Adélaide, Emerence Crompot, Ludovic Berger, Olivier Cabaud
Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcec6c70e62d58c92f36ed64744fda8
https://doi.org/10.1158/1535-7163.22522941.v1
https://doi.org/10.1158/1535-7163.22522941.v1
Autor:
Marc Lopez, François Bertucci, Daniel Birnbaum, Emilie Mamessier, Emmanuelle Charafe-Jauffret, Anthony Gonçalves, Max Chaffanet, Emilie Agavnian, Anne Farina, Nadine Carbuccia, Arnaud Guille, Sèverine Garnier, Pascal Finetti, José Adélaide, Emerence Crompot, Ludovic Berger, Olivier Cabaud
Supplementary Table from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d22afca939de56fc4c7c9c9f5a913e7
https://doi.org/10.1158/1535-7163.22522929.v1
https://doi.org/10.1158/1535-7163.22522929.v1
Autor:
Marc Lopez, François Bertucci, Daniel Birnbaum, Emilie Mamessier, Emmanuelle Charafe-Jauffret, Anthony Gonçalves, Max Chaffanet, Emilie Agavnian, Anne Farina, Nadine Carbuccia, Arnaud Guille, Sèverine Garnier, Pascal Finetti, José Adélaide, Emerence Crompot, Ludovic Berger, Olivier Cabaud
Antibody–drug conjugates (ADC) represent a fast-growing drug class in oncology. However, ADCs are associated with resistance, and therapies able to overcome it are of utmost importance. Recently, enfortumab vedotin-ejfv (EV) was approved in nectin-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ceab29cf01babf6ad7765fd0c7532cb
https://doi.org/10.1158/1535-7163.c.6543528
https://doi.org/10.1158/1535-7163.c.6543528
Autor:
Anna Schuh, Hélène Dreau, Andreas Heger, David Sims, Fritz Offner, Bruno Verhasselt, Jan Philippé, André Efira, Virginie De Wilde, Marie Maerevoet, Radu Firescu, Philippe Mineur, Nathalie Meuleman, Peter Hillmen, David Bruce, Adele Timbs, Adam Burns, Pauline Robbe, Marek Mraz, Ruth Clifford, Karlien Pieters, Emerence Crompot, Thomas Smith, Basile Stamatopoulos
Supplementary Data Table S1: general characterisctic of the different cohorts of patients Supplementary Data Table S2: characterisctic of Population A Supplementary Data Table S3: characterisctic of Population B Supplementary Data Table S4: character
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8b6261612d72e47a04ba5cab498fb5
https://doi.org/10.1158/1078-0432.22474745
https://doi.org/10.1158/1078-0432.22474745